» Authors » Hongguo Zhao

Hongguo Zhao

Explore the profile of Hongguo Zhao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 204
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao H, Liu P, Chen F, Wang M, Liu J, Fu X, et al.
Sci Rep . 2025 Jan; 15(1):3147. PMID: 39856162
This study develops predictive models for Chinese female patients with VL utilizing machine learning techniques. The aim is to create an effective model that can assist in clinical diagnosis and...
2.
Li Z, Jiang W, Zhou H, Cen H, Zhang M, Lv F, et al.
J Immunother Cancer . 2024 Oct; 12(10). PMID: 39455094
Background: In patients with untreated CD20-positive diffuse large B-cell lymphoma (DLBCL), a phase 3 trial was carried out to evaluate the efficacy and safety of zuberitamab plus CHOP (cyclophosphamide, doxorubicin,...
3.
Luan C, Zhu Y, Zhao H
Patient Prefer Adherence . 2024 Sep; 18:1961-1964. PMID: 39323606
Gynecomastia refers to the abnormal enlargement of the male breast caused by the proliferation of the glandular component of the breast, typically due to sexual hormone disturbance. Multiple medications have...
4.
Su Z, Du Y, Yuan C, Zhao X, Zhang X, Cui H, et al.
Virchows Arch . 2024 Aug; PMID: 39186080
Fusion genes generally serve as driver mutations in leukemia. The rearrangement of the RARA gene located on chromosome 17q21 is a molecular pathological feature of acute promyelocytic leukemia (APL). A...
5.
Luan C, Zhao H, Ding Y
Int J Lab Hematol . 2024 Jun; 46(5):770-776. PMID: 38923828
Bone marrow necrosis (BMN) is a clinically and pathologically poorly-defined and readily-overlooked entity. The current facts and guidelines pertaining to this entity are scarce, and there exist controversies. Upon reviewing...
6.
Yu H, Zhao H, Liu D, Dong Y, Nai M, Song Y, et al.
Heliyon . 2024 Jun; 10(11):e31928. PMID: 38868063
Objective: The objective is to construct a random forest model for predicting the occurrence of Myofascial pelvic pain syndrome (MPPS) and compare its performance with a logistic regression model to...
7.
Wang Q, Xu H, Yu W, Sun L, Zhao H, Shi X
Am J Case Rep . 2024 Apr; 25:e943801. PMID: 38632857
BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important treatment for severe aplastic anemia (SAA). It is known that SAA can evolve into malignant clonal diseases, such as acute...
8.
Liu H, Jiang H, Tong H, Xia R, Yang L, Zhao H, et al.
Cancer Med . 2023 Jun; 12(13):13885-13893. PMID: 37350499
Background: The hypomethylating agent decitabine is the standard therapy for intermediate or high risk myelodysplastic syndrome (MDS). Methods: In this trial, 191 adult patients with intermediate/high risk MDS (IPSS score ...
9.
Xu H, Ma J, Yang G, Xiao S, Li W, Sun Y, et al.
Eur J Radiol . 2023 Apr; 163:110798. PMID: 37030099
Purpose: The purpose of this study was to determine the prognostic value of metabolic tumor volume and lesion dissemination from baseline PET/CT in patients with diffuse large B-cell lymphoma (DLBCL)...
10.
Fei H, Liu X, Sun L, Shi X, Wang W, Zhao H, et al.
Medicine (Baltimore) . 2022 Nov; 101(45):e31594. PMID: 36397380
Background: Fusarium is a conditional pathogen that can cause invasive infection in patients with hematological diseases under immune function. Methods: A case of recurrent and refractory Philadelphia chromosome-positive acute lymphoblastic...